APEX1 and cancer: Although the molecular basis of changing the subcellular localization is not clear, the cytoplasmic distribution of APEX1 has been reported to be associated with aggressiveness in some cancers including lung, ovarian, thyroid, breast, and liver cancers [25,26,27].